Publications by authors named "Victor M Rivera"

77Publications

Current Advances in Pediatric Onset Multiple Sclerosis.

Biomedicines 2020 Mar 28;8(4). Epub 2020 Mar 28.

Baylor College of Medicine, Maxine Mesinger Multiple Sclerosis Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biomedicines8040071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235875PMC
March 2020

Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?

Authors:
Victor M Rivera

Neurol Ther 2019 Dec 16;8(2):177-184. Epub 2019 Jul 16.

Baylor College of Medicine, Houston, TX, 77025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40120-019-0145-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858917PMC
December 2019

Multiple Sclerosis: A Global Concern with Multiple Challenges in an Era of Advanced Therapeutic Complex Molecules and Biological Medicines.

Authors:
Victor M Rivera

Biomedicines 2018 Nov 30;6(4). Epub 2018 Nov 30.

Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2227-9059/6/4/112
Publisher Site
http://dx.doi.org/10.3390/biomedicines6040112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316848PMC
November 2018

RET fusions observed in lung and colorectal cancers are sensitive to ponatinib.

Oncotarget 2018 Jul 3;9(51):29654-29664. Epub 2018 Jul 3.

ARIAD Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/25664
Publisher Site
http://dx.doi.org/10.18632/oncotarget.25664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049858PMC
July 2018

Multiple Sclerosis in Latin Americans: Genetic Aspects.

Authors:
Victor M Rivera

Curr Neurol Neurosci Rep 2017 Aug;17(8):57

Department of Neurology, Baylor College of Medicine, 3838 N. Braeswood Blvd # 418, Houston, TX, 77025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-017-0768-4DOI Listing
August 2017

Access and barriers to MS care in Latin America.

Mult Scler J Exp Transl Clin 2017 Jan-Mar;3(1):2055217317700668. Epub 2017 Mar 23.

University of Guadalajara, Guadalajara, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217317700668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433222PMC
March 2017

Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice.

Oncotarget 2016 May;7(20):29011-22

Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045374PMC
May 2016

The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib.

Blood 2016 Apr 14;127(15):1870-80. Epub 2016 Jan 14.

Department of Genetics and Molecular Pathology and School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia; School of Medicine, University of Adelaide, Adelaide, Australia; School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-09-666214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832506PMC
April 2016

Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients.

Blood 2016 Feb 24;127(6):703-12. Epub 2015 Nov 24.

Department of Genetics and Molecular Pathology, SA Pathology, Centre for Cancer Biology, School of Medicine and School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia; and School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-08-660977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760131PMC
February 2016

Multiple sclerosis care in Latin America.

Neurology 2014 May;82(18):1660-1

From the Department of Neurology (V.M.R.), Baylor College of Medicine, Houston, TX; National Autonomous University of Honduras (M.T.M., R.M.D.), Tegucigalpa; and University of Guadalajara (M.A.M.), Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013811PMC
May 2014

Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.

Acta Neurol Belg 2013 Dec 14;113(4):415-20. Epub 2013 May 14.

Jefe del Departamento de Neurología, UMAE, Centro Médico Nacional de Occidente, IMSS, Belisario Domínguez #1000, Col. Independencia Oriente, C.P. 44340, Guadalajara, Jal, Mexico,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13760-013-0200-zDOI Listing
December 2013

Dimerizer-mediated regulation of gene expression in vivo.

Cold Spring Harb Protoc 2012 Jul 1;2012(7):821-4. Epub 2012 Jul 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/pdb.prot070144DOI Listing
July 2012

Dimerizer-mediated regulation of gene expression in vitro.

Cold Spring Harb Protoc 2012 Jul 1;2012(7):815-20. Epub 2012 Jul 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/pdb.prot070136DOI Listing
July 2012

Dimerizer-mediated regulation of gene expression.

Cold Spring Harb Protoc 2012 Jul 1;2012(7):767-70. Epub 2012 Jul 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/pdb.top070128DOI Listing
July 2012

Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial.

Cancer Chemother Pharmacol 2012 Apr 30;69(4):849-60. Epub 2011 Oct 30.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue-SW G460F, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1773-yDOI Listing
April 2012

The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.

Int J MS Care 2011 ;13(2):91-3

Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7224/1537-2073-13.2.91DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882955PMC
January 2014

Assessment of the safety and biodistribution of a regulated AAV2 gene transfer vector after delivery to murine submandibular glands.

Toxicol Sci 2011 Sep 30;123(1):247-55. Epub 2011 May 30.

Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/toxsci/kfr144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164441PMC
September 2011

Tovaxin for multiple sclerosis.

Authors:
Victor M Rivera

Expert Opin Biol Ther 2011 Jul 12;11(7):961-7. Epub 2011 May 12.

Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2011.584866DOI Listing
July 2011

Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine.

J Clin Oncol 2010 Oct 20;28(30):4554-61. Epub 2010 Sep 20.

Montabone Unit for New Drug Development, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto dei Tumori di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.5867DOI Listing
October 2010

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis.

Curr Med Res Opin 2010 Apr;26(4):827-38

Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007991003604018DOI Listing
April 2010

Exocytosis of post-Golgi vesicles is regulated by components of the endocytic machinery.

Cell 2009 Jun;137(7):1308-19

The Rockefeller University, 1230 York Avenue, Box 304, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2009.04.064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237386PMC
June 2009

Multiple sclerosis in Latin America: reality and challenge.

Authors:
Victor M Rivera

Neuroepidemiology 2009 27;32(4):294-5. Epub 2009 Feb 27.

Baylor College of Medicine, Houston, Tex., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000204913DOI Listing
June 2009

A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.

Clin Cancer Res 2009 Feb;15(4):1428-34

Department of Pediatrics, Cancer Research Center, and Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147153PMC
February 2009

Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome.

Clin Neurol Neurosurg 2007 Jan 19;109(1):102-5. Epub 2006 Apr 19.

Maxine Mesinger MS Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2006.03.009DOI Listing
January 2007

The terms Latino and Anglo and tendency to early Alzheimer disease.

Authors:
Victor M Rivera

Arch Neurol 2005 Nov;62(11):1787; author reply 1787-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.62.11.1787-aDOI Listing
November 2005

Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates.

Hum Gene Ther 2005 Feb;16(2):178-86

Gene Therapy Program, Department of Medicine, Division of Medical Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2005.16.178DOI Listing
February 2005

Pharmacologically regulated regeneration of functional human pancreatic islets.

Mol Ther 2005 Jan;11(1):105-11

Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2004.09.010DOI Listing
January 2005

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

Blood 2005 Feb 26;105(4):1424-30. Epub 2004 Oct 26.

ARIAD Gene Therapeutics Inc, 26 Landsdowne St, Cambridge, MA 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-06-2501DOI Listing
February 2005

Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis.

Mult Scler 2004 Oct;10(5):499-506

Multiple Sclerosis Research Unit, Department of Neurology and Baylor Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1191/1352458504ms1081oaDOI Listing
October 2004

Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.

J Neuroimmunol 2004 Jul;152(1-2):126-39

Department of Neurology and Baylor-Methodist Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2004.03.004DOI Listing
July 2004

Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.

J Immunol 2004 Apr;172(8):5120-7

Multiple Sclerosis Research Unit, Department of Neurology and Baylor Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.172.8.5120DOI Listing
April 2004

Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes.

Eur J Immunol 2004 Mar;34(3):870-881

Department of Neurology and Baylor-Methodist Multiple Sclerosis Center, Baylor College of Medicine, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200324790DOI Listing
March 2004

Regulation of gene expression by synthetic dimerizers with novel specificity.

Bioorg Med Chem Lett 2003 Oct;13(19):3181-4

ARIAD Gene Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA 02139-4234, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(03)00707-8DOI Listing
October 2003

Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.

Int Immunol 2003 Sep;15(9):1073-80

Multiple Sclerosis Research Unit, Department of Neurology and Baylor-Methodist Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxg105DOI Listing
September 2003

Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model.

Mol Ther 2003 Apr;7(4):493-7

The Department of Medicine, Division of Medical Genetics, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1525-0016(03)00043-1DOI Listing
April 2003

Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis.

J Neuroimmunol 2003 Apr;137(1-2):144-53

Multiple Sclerosis Research Unit, Department of Neurology and Baylor Multiple Sclerosis Center, Baylor College of Medicine, 6501 Fannin Street, NB302, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-5728(03)00049-3DOI Listing
April 2003

Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis.

Ann Neurol 2003 Feb;53(2):189-97

Multiple Sclerosis Research Unit, Department of Neurology and Baylor Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.10425DOI Listing
February 2003

Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.

Immunology 2002 Dec;107(4):403-10

Multiple Sclerosis Research Unit, Baylor-Methodist Multiple Sclerosis Center and Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1782818PMC
http://dx.doi.org/10.1046/j.1365-2567.2002.01533.xDOI Listing
December 2002

Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.

Mol Ther 2002 Aug;6(2):238-42

Institute for Human Gene Therapy, The Wistar Institute, Department of Molecular and Cellular Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/mthe.2002.0660DOI Listing
August 2002

Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls.

J Virol 2002 Jun;76(12):6147-54

Multiple Sclerosis Research Unit, Department of Neurology and Baylor-Methodist Multiple Sclerosis Center, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC136216PMC
http://dx.doi.org/10.1128/jvi.76.12.6147-6154.2002DOI Listing
June 2002

T cell vaccination in multiple sclerosis: results of a preliminary study.

J Neurol 2002 Feb;249(2):212-8

Department of Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/pl00007867DOI Listing
February 2002

Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B.

J Neuroimmunol 2002 Mar;124(1-2):106-14

Multiple Sclerosis Research Unit, Baylor-Methodist Multiple Sclerosis Center and Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-5728(02)00016-4DOI Listing
March 2002

A system for small-molecule control of conditionally replication-competent adenoviral vectors.

Mol Ther 2002 Feb;5(2):195-203

Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/mthe.2002.0531DOI Listing
February 2002